ABSTRACT
Objective In absence of any vaccine, the Corona Virus Disease 2019 (COVID-19) pandemic is being contained through a non-pharmaceutical measure termed Social Distancing (SD). However, whether SD alone is enough to flatten the epidemic curve is debatable. Using a Stochastic Computational Simulation Model, we investigated the impact of increasing SD, hospital beds and COVID-19 detection rates in preventing COVID-19 cases and fatalities.
Research Design and Methods The Stochastic Simulation Model was built using the EpiModel package in R. As a proof of concept study, we ran the simulation on Kasaragod, the most affected district in Kerala. We added 3 compartments to the SEIR model to obtain a SEIQHRF (Susceptible-Exposed-Infectious-Quarantined-Hospitalised-Recovered-Fatal) model.
Results Implementing SD only delayed the appearance of peak prevalence of COVID-19 cases. Doubling of hospital beds couldn’t reduce the fatal cases probably due to its overwhelming number compared to the hospital beds. Increasing detection rates could significantly flatten the curve and reduce the peak prevalence of cases (increasing detection rate by 5 times could reduce case number to half).
Conclusions An effective strategy to contain the epidemic spread of COVID-19 in India is to increase detection rates in combination with SD measures and increase in hospital beds.
HIGHLIGHTS
Increased Detection of COVID-19 cases must accompany Social Distancing and Health Capacity Planning to reduce the burden of cases and fatalities.
Interruptive Social Distancing is an effective alternative to continuous Social Distancing.
Given the overwhelming burden of COVID-19 fatalities, there is immediate need of co-ordination with the Private Healthcare Sector.
COVID-19 cases will be peaking after May, 2020 giving us time for Healthcare Capacity Building in the government and private sector both.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
JS received a research fellowship from ICMR (No.3/1/3/JRF-2017/HRD-LS/56429/54).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Not Applicable
